Lexicon Pharmaceuticals Company
Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.
Total Funding:
$36M
Headquarters:
The Woodlands, Texas, United States
Funding Status:
IPO
Employee Number:
251-500
Estimated Revenue:
$100M to $500M
Last Funding Type:
Series C
Technology:
Biologics
Investor Type:
For Profit
Investors Number:
4
Founded Date:
1995
Industry:
PharmTech